ALLUMINOX Trademark

Trademark Overview


On Friday, October 8, 2021, a trademark application was filed for ALLUMINOX with the United States Patent and Trademark Office. The USPTO has given the ALLUMINOX trademark a serial number of 97065108. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, April 8, 2024. This trademark is owned by Rakuten Medical, Inc.. The ALLUMINOX trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, providing classes, seminars, and lectures, all in the field of treatment of cancer; providing training in the oncology field; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing

Providing medical information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; counseling services, namely, medical counseling for patients diagnosed with cancer related to prevention and treatment; information services in the field of treating cancer; Providing online information services, namely, prescription drug medical information; Providing information in the field of medicine; providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing an Internet website featuring information and content about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing an online searchable database featuring articles and information about cancer, cancer recovery, cancer ...

Scientific, biological, and medical research; conducting clinical trials for others for the purpose of advancing knowledge and developing new approaches; providing prescription scientific drug research information by means of providing links to third party websites relating to cancer drugs; Providing temporary use of on-line non-downloadable software for tracking and storing personal information about the symptoms, side effects, treatment of and experience with an individual's cancer, logging daily actions and results of activity and cognitive tests, and sharing results based on such information; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing
alluminox

General Information


Serial Number97065108
Word MarkALLUMINOX
Filing DateFriday, October 8, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, April 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2022

Trademark Statements


Goods and ServicesEducational services, namely, providing classes, seminars, and lectures, all in the field of treatment of cancer; providing training in the oncology field; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing
Goods and ServicesProviding medical information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; counseling services, namely, medical counseling for patients diagnosed with cancer related to prevention and treatment; information services in the field of treating cancer; Providing online information services, namely, prescription drug medical information; Providing information in the field of medicine; providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing an Internet website featuring information and content about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing an online searchable database featuring articles and information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing healthcare information regarding cancer drugs and cancer treatment; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing
Goods and ServicesScientific, biological, and medical research; conducting clinical trials for others for the purpose of advancing knowledge and developing new approaches; providing prescription scientific drug research information by means of providing links to third party websites relating to cancer drugs; Providing temporary use of on-line non-downloadable software for tracking and storing personal information about the symptoms, side effects, treatment of and experience with an individual's cancer, logging daily actions and results of activity and cognitive tests, and sharing results based on such information; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRakuten Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameRakuten Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94402

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2024SOU EXTENSION 3 GRANTED
Monday, April 8, 2024SOU EXTENSION 3 FILED
Monday, April 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 24, 2023SOU EXTENSION 2 GRANTED
Tuesday, October 24, 2023SOU EXTENSION 2 FILED
Tuesday, October 24, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 11, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 11, 2023SOU EXTENSION 1 FILED
Tuesday, April 11, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 15, 2022NON-FINAL ACTION E-MAILED
Friday, July 15, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 13, 2022ASSIGNED TO EXAMINER
Thursday, December 23, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, December 23, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, November 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 12, 2021NEW APPLICATION ENTERED